First‐line immune‐based combination therapies for advanced non‐small cell lung cancer: A Bayesian network meta‐analysis

BACKGROUND: Immune‐based combination therapies have revolutionized the first‐line treatment for advanced non‐small cell lung cancer (NSCLC). However, for the efficacy and safety, the best treatment option is still uncertain. METHODS: We conducted a Bayesian network meta‐analysis of randomized contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Ziyang, Jiang, Panpan, Zhang, Yajuan, Li, Yanlin, Jia, Xiaohui, Wang, Qinyang, Jiao, Min, Jiang, Lili, Shen, Yuan, Guo, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683544/
https://www.ncbi.nlm.nih.gov/pubmed/34747149
http://dx.doi.org/10.1002/cam4.4405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683544/
https://www.ncbi.nlm.nih.gov/pubmed/34747149
http://dx.doi.org/10.1002/cam4.4405

Ejemplares similares